Resveratrol ameliorates obesity and dyslipidemia via increasing KLF5 phosphorylation and interfering with the interaction between KLF5 and c-Myc, which subsequently modulates lipid metabolism balance (Yang et al., 2017b). The gene discussed is KLF5; the disease is obesity due to melanocortin 4 receptor deficiency.